Glucose transport inhibitors protect against 1,2-cyclohexanedione-produced potassium loss from human red blood cells.
It has been suggested that the glucose transport system of human erythrocytes contains an arginine shield to prevent the leak of potassium through the transporter. To investigate this suggestion we treated human erythrocytes with the specific arginine reagent 1,2-cyclohexanedione. Under conditions which produce a covalent reaction between arginine and the reagent, a steady leak of potassium occurs. If glucose, maltose or the inhibitor phloretin are present during the reaction the extent of the leak is reduced. These findings support the view that arginines have a role in preventing potassium loss through the glucose transporter.
Baker
G F
GF
Department of Biological Sciences, University of London, Egham, Surrey, UK. g.baker@rhbnc.ac.uk
O'Gorman
R
R
Baker
P
P
D001120:Arginine / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism*; D003512:Cyclohexanones / Q000494:pharmacology*; D003571:Cytochalasin B / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D005665:Furosemide / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008320:Maltose / Q000494:pharmacology; D009004:Monosaccharide Transport Proteins / Q000037:antagonists & inhibitors* / Q000097:blood; D010693:Phloretin / Q000494:pharmacology; D011188:Potassium / Q000097:blood*
D001786:Blood Glucose; D003512:Cyclohexanones; D009004:Monosaccharide Transport Proteins; D003571:Cytochalasin B; D008320:Maltose; C018031:1,2-cyclohexanedione; D005665:Furosemide; D001120:Arginine; D005947:Glucose; D011188:Potassium; D010693:Phloretin